Share
Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab
LEUKEMIA
Fink, AM; Bottcher, S; Ritgen, M; Fischer, K; Pflug, N; Eichhorst, B; Wendtner, CM; Winkler, D; Buhler, A; Zenz, T; Staib, P; Mayer, J; Hensel, M; Hopfinger, G; Wenger, M; Fingerle-Rowson, G; Dohner, H; Kneba, M; Stilgenbauer, S; Busch, R; Hallek, M, 2013: Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab. LEUKEMIA 27(9), p. 1949 - 1952, doi: 10.1038/leu.2013.190
CEITEC authors: